Premium
Clearance of head and neck involvement in plaque psoriasis with tildrakizumab treatment in the phase 3 reSURFACE 1 study
Author(s) -
Menter M.A.,
Murakawa G.J.,
Glover H.,
Mendelsohn A.M.,
Parno J.,
Rozzo S.J.,
Davidson D.,
Gupta A.K.
Publication year - 2020
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/jdv.16648
Subject(s) - medicine , placebo , psoriasis area and severity index , psoriasis , interquartile range , ixekizumab , gastroenterology , surgery , dermatology , secukinumab , psoriatic arthritis , pathology , alternative medicine